PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Company ReportsImpel Pharmaceuticals
Impel Pharmaceuticals(IMPL)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Loading
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Plot placeholder
Mock data
Subscribe for the real data
Revenue by Drug
Loading
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
TrudhesaDihydroergotamine2021-09-022032-2039
Migraine disorders
,
Orthostatic hypotension
,
Cluster headache
,
Postpartum hemorrhage
,
Xerostomia
,
Myocardial infarction
,
Pulmonary embolism
,
Postoperative complications
,
Pain
,
Thromboembolism
,
Cerebral infarction
,
Ventricular tachycardia
,
Coronary thrombosis
,
Unstable angina
,
Cardiac arrhythmias
,
Burns
,
Esophageal diseases
,
Thrombophlebitis
,
Ventricular fibrillation
,
Ventricular premature complexes
,
Mouth diseases
,
Paroxysmal tachycardia
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Dihydroergotamine
renal insufficiency
Benserazide
parkinson disease
Ssri
psychomotor agitation
Pbo
psychomotor agitation
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use